TCG Crossover Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001839948

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2026 · 56 positions · Total reported value $3.54B · Top-10 concentration 53.3% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 44.3% · 7 new · 15 cut · 5 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -7.6% · vs SPY -9.8% · Prev Value $4.16B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.9% · vs SPY -5.0% · Latest Value $3.54B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, TCG Crossover Management, LLC disclosed 56 equity positions with a combined reported value of $3.54B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 53.3% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were ABVX ($362.71M), CGON ($260.18M), AMLX ($181.69M). By sector, the heaviest allocations are Health Care 99.8%, Financials 0.1%.

Versus the prior quarter, TCG Crossover Management, LLC opened 7 new positions, trimmed 15 and fully exited 5, a turnover rate of 44.3% of positions. The portfolio's overlap with the prior quarter was 80% of names.

The largest new positions opened in Q3 2026 were ANIX ($145.59M), VNDA ($82.08M), ENTX ($35.66M).

Of the 5 positions fully exited versus the prior quarter, the largest were RVMD ($63.84M), SRZN ($38.23M), ALT ($30.40M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • ANIX KORSANA BIOSCIENCES INC · $145.59M
  • VNDA VANDA PHARMACEUTICALS INC · $82.08M
  • ENTX ENTERA BIO LTD · $35.66M
  • TARS TARSUS PHARMACEUTICALS INC · $30.51M
  • VRDN VIRIDIAN THERAPEUTICS INC · $30.15M
  • AGEN AGENUS INC · $6.00M
  • RACD RESEARCH ALLIANCE CORP IV · $3.60M

Fully Exited (vs previous quarter)

  • RVMD REVOLUTION MEDICINES INC · prev qtr: $63.84M
  • SRZN SURROZEN INC · prev qtr: $38.23M
  • ALT ALTIMMUNE INC · prev qtr: $30.40M
  • FBRX FORTE BIOSCIENCES INC · prev qtr: $19.55M
  • RACC RESEARCH ALLIANCE CORP III · prev qtr: $5.35M

Insider Transactions (Form 4)

Latest TCG Crossover Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

TCG Crossover Management, LLC, based in Palo Alto, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 54 positions worth $4.16B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: PALO ALTO, CA, United States
  • SEC registration: 801-120001 (status: Approved), registered 2020-12-18
  • Regulatory AUM (Form ADV): $5.06B as of 2026-05-29
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds
  • Website: tcgcrossover.com

Portfolio Structure

  • 54 positions · $4.16B reported value (Q2 2026)
  • Top 10 holdings = 57.4% of reported value
  • Largest position: ABVX (ABIVAX SA) at 19.2%
  • Average position size: $77.05M

Sector Tilt

  • Health Care 99.3%
  • Financials 0.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 12 new, 2 added, 9 reduced, 7 exited
  • 31 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund reduced exposure to large biotech positions (ABVX, TNGX) while adding smaller/mid-cap names (ZLAB, ANIX), suggesting a cautious view on overvalued large caps and appetite for higher-risk/reward catalysts in biotech/Health Care. 2. Key moves: - Reduced: ABVX (shares -39.0%, wt -9.0pp), TNGX (shares -25.4%, wt -2.1pp). - Added: ZLAB (shares +1.5%, wt +1.8pp), ANIX (new position, wt 4.1%). - New: ANIX (Korsana Biosciences). 3. Portfolio structure: Active, concentrated (56 positions), heavily biased toward Health Care (100% of top 10), with moderate risk appetite (mix of clinical-stage biotechs and established names). 4. Per-holding one-liner: - ABVX: Abivax SA (biopharma, unverified). - CGON: CG Oncology (cancer immunotherapy, unverified). - AMLX: Amylyx Pharmaceuticals (ALS/neuro treatments, unverified). - SYRE: Spyre Therapeutics (inflammation/autoimmunity, unverified). - TNGX: Tango Therapeutics (oncology, unverified). - ZLAB: Zai Lab (oncology/inflammation, unverified). - IMVT: Immunovant (autoimmunity, unverified). - DNTH: Dianthus Therapeutics (kidney disease, unverified). - ANIX: Korsana Biosciences (neurodegeneration, unverified). - KOD: Kodiak Sciences (eye diseases, unverified). 5. Style summary: Rotating from large-cap biotech to higher-conviction mid-caps in Health Care, with selective reductions and new bets on clinical-stage catalysts.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 04:08

Sector Allocation

Health Care 99.8%
Financials 0.1%
Other 0.1%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 3.66M $362.71M 10.25%
10.25%
Reduce
2 3.67M $260.18M 7.35%
7.35%
Hold
3 6.24M $181.69M 5.13%
5.13%
Hold
4 1.90M $169.21M 4.78%
4.78%
Hold
5 6.77M $168.99M 4.77%
4.77%
Reduce
6 6.23M $164.07M 4.63%
4.63%
Add
7 4.46M $150.59M 4.25%
4.25%
Hold
8 1.68M $147.63M 4.17%
4.17%
Hold
9 4.55M $145.59M 4.11%
4.11%
New
10 1.45M $137.04M 3.87%
3.87%
Hold
11 5.67M $108.24M 3.06%
3.06%
Hold
12 2.90M $102.61M 2.90%
2.90%
Hold
13 1.12M $95.65M 2.70%
2.70%
Add
14 11.02M $91.80M 2.59%
2.59%
Hold
15 1.34M $87.84M 2.48%
2.48%
Hold
16 4.12M $82.08M 2.32%
2.32%
New
17 2.50M $80.05M 2.26%
2.26%
Reduce
18 3.48M $76.02M 2.15%
2.15%
Add
19 4.62M $74.35M 2.10%
2.10%
Hold
20 3.78M $68.29M 1.93%
1.93%
Reduce
21 10.17M $63.84M 1.80%
1.80%
Add
22 12.36M $63.79M 1.80%
1.80%
Hold
23 2.06M $51.30M 1.45%
1.45%
Reduce
24 3.02M $46.25M 1.31%
1.31%
Hold
25 3.78M $45.11M 1.27%
1.27%
Reduce
26 650.00K $38.10M 1.08%
1.08%
Hold
27 12.25M $35.66M 1.01%
1.01%
New
28 1.79M $30.92M 0.87%
0.87%
Hold
29 388.16K $30.51M 0.86%
0.86%
New
30 17.75M $30.36M 0.86%
0.86%
Hold
31 2.20M $30.15M 0.85%
0.85%
New
32 947.54K $30.06M 0.85%
0.85%
Reduce
33 765.05K $29.36M 0.83%
0.83%
Reduce
34 11.11M $28.56M 0.81%
0.81%
Hold
35 1.20M $28.06M 0.79%
0.79%
Hold
36 14.50M $26.10M 0.74%
0.74%
Hold
37 7.92M $21.77M 0.61%
0.61%
Hold
38 1.82M $20.21M 0.57%
0.57%
Reduce
39 1.82M $19.88M 0.56%
0.56%
Reduce
40 10.00M $18.50M 0.52%
0.52%
Hold
41 1.26M $16.85M 0.48%
0.48%
Reduce
42 202.24K $16.11M 0.46%
0.46%
Reduce
43 11.39M $13.90M 0.39%
0.39%
Hold
44 1.06M $6.73M 0.19%
0.19%
Hold
45 406.79K $6.24M 0.18%
0.18%
Hold
46 603.89K $6.00M 0.17%
0.17%
New
47 720.32K $5.52M 0.16%
0.16%
Reduce
48 707.10K $5.47M 0.15%
0.15%
Hold
49 416.30K $4.13M 0.12%
0.12%
Hold
50 300.00K $3.60M 0.10%
0.10%
New

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q2)

P 70% R 70% F1 70% (modelled on 2026-Q1; 7/10 hit)

Low-confidence forecast This fund replaces about 34% of its Top-10 each quarter and backtests at F1 67% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (10 quarters)

Avg precision 67% · recall 67% · F1 67% · avg rank error 2.9 · Top-10 turnover 34%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 50% 50% 50% GPCR · INBX · ICVX · ANTX · RYZB · GRCL · AVTE · GERN · SVRA · MDGL CGON · DYN · ATXS · SLN · GPCR · AVTE · INBX · KROS · GERN · SVRA
2024-Q2 50% 50% 50% CGON · DYN · SLN · ATXS · GPCR · AVTE · INBX · KROS · GERN · SVRA CGON · DYN · ABVX · SLN · COGT · SVRA · MDGL · EWTX · KROS · MLYS
2024-Q3 80% 80% 80% CGON · DYN · ABVX · SLN · COGT · SVRA · MDGL · EWTX · KROS · MLYS CGON · DYN · COGT · ABVX · EWTX · SLN · SVRA · KROS · XNCR · TYRA
2024-Q4 70% 70% 70% CGON · DYN · ABVX · COGT · EWTX · SLN · SVRA · KROS · XNCR · CNTA CGON · DYN · XNCR · COGT · CNTA · OCUL · UPB · ABVX · SVRA · TNGX
2025-Q1 80% 80% 80% CGON · DYN · XNCR · COGT · CNTA · OCUL · UPB · ABVX · SVRA · DNTH CGON · COGT · CNTA · MLYS · OCUL · ABVX · SVRA · DYN · DNTH · TYRA
2025-Q2 60% 60% 60% CGON · COGT · CNTA · MLYS · OCUL · ABVX · SVRA · TYRA · DYN · DNTH CGON · TNGX · COGT · OCUL · CDTX · ABVX · AMLX · CNTA · FULC · DYN
2025-Q3 80% 80% 80% CGON · TNGX · COGT · OCUL · CDTX · ABVX · AMLX · CNTA · DYN · FULC ABVX · CGON · COGT · AMLX · CNTA · TNGX · OCUL · DNTH · TRML · DYN
2025-Q4 70% 70% 70% ABVX · CGON · COGT · AMLX · CNTA · OCUL · TNGX · DNTH · AGIO · DYN ABVX · COGT · CGON · TNGX · CNTA · DYN · RAPT · TYRA · AMLX · SVRA
2026-Q1 60% 60% 60% ABVX · COGT · CGON · TNGX · CNTA · RAPT · DYN · TYRA · AMLX · SVRA ABVX · CGON · TNGX · COGT · CNTA · DNTH · TYRA · IMVT · BCRX · MIRM
2026-Q2 ★ 70% 70% 70% ABVX · CGON · TNGX · COGT · CNTA · DNTH · TYRA · IMVT · MIRM · BCRX ABVX · TNGX · CGON · COGT · IMVT · SYRE · DNTH · MIRM · ZLAB · AMLX

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-13. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-13 Trading days32 Holdings3 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-13, and will update as prices arrive.

Portfolio return-1.53%Buy & hold
QQQ synthetic benchmark-13.72%Liquidity weighted
Excess return+12.18%vs benchmark
Barra annualised vol81.8%Model estimate
Realised vol70.6%Annualised in window
Weighted beta1.51Raw exposure
Factor / specific risk29% / 71%Share of variance
Top-10 concentration100.0%Of reported value
Portfolio value (start = 100)78.185.993.7101.5109.310-0110-2311-13TCG Crossover Management, LLCQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)-1.53%Disclosed long book
QQQ synthetic benchmark-13.72%Liquidity-weighted constituents
Model universe, equal weight+0.30%Opportunity-cost reference
Excess return+12.18%Portfolio − benchmark
Arithmetic return sum+1.58%Difference vs compounded is the cross term
Weighted raw beta1.51Weighted holding betas
Realised volatility (annualised)70.64%Daily returns in window
Barra model volatility (annualised)81.79%Factor + specific
Factor share of variance28.8%Barra factors
Specific share of variance71.2%Stock residuals
Reported value$257.5M13F long US equity

2. Return attribution

The +1.58% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 -1.98% -125.2%
Momentum & Growth 3 -11.78% -744.8%
Volatility & Tail Risk 7 -6.99% -442.1%
Industry 12 +8.12% 513.7%
Specific 1 +14.20% 898.4%
Return attribution (style + industry, %)-13.9-6.9+0.0+6.9+13.9Skewness-0.76Leverage (Downside Vol)-1.04Amihud Illiquidity-1.11Growth-1.53Turnover-2.30Kurtosis-2.34Non-linear Size+2.81Size+3.04Beta+3.24Mid Cap-4.52Residual Volatility+7.24Health Care+8.12Momentum-10.08Historical Volatility-12.84
Factor Type Exposure Factor return Contribution Share of |return|
Specific Specific — — +14.20% 898.4%
Health Care Industry +1.00 +8.12% +8.12% 513.7%
Residual Volatility Style +2.72 +2.66% +7.24% 457.6%
Beta Style +0.67 +4.85% +3.24% 205.1%
Size Style -1.66 -1.83% +3.04% 192.1%
Non-linear Size Style +3.07 +0.91% +2.81% 177.6%
Liquidity Style +0.51 +0.22% +0.11% 7.0%
Short-term Reversal Style -0.21 +0.79% -0.16% -10.4%
Max Drawdown Style +0.25 -1.96% -0.50% -31.4%
Skewness Style +0.18 -4.21% -0.76% -48.1%
Leverage (Downside Vol) Style +0.57 -1.82% -1.04% -65.5%
Amihud Illiquidity Style +2.75 -0.40% -1.11% -70.2%
Growth Style -0.98 +1.57% -1.53% -97.1%
Turnover Style +0.48 -4.77% -2.30% -145.7%
Kurtosis Style -0.34 +6.97% -2.34% -147.8%
Mid Cap Style +2.67 -1.69% -4.52% -286.0%
Momentum Style +3.02 -3.34% -10.08% -637.3%
Historical Volatility Style +1.00 -12.86% -12.84% -811.9%

3. Risk attribution

Annualised volatility is 81.79%; factor risk explains 28.8% of variance and specific risk 71.2%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-76.9-38.5+0.0+38.5+76.9Liquidity+0.22Leverage (Downside Vol)+0.47Amihud Illiquidity+1.18Non-linear Size+1.21Beta+2.07Historical Volatility+2.07Size+2.26Residual Volatility+3.41Mid Cap+4.10Health Care+4.20Momentum+7.16Specific+71.22
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 71.2% +58.24% 58.2%
Momentum Style +3.02 7.2% +5.86% 5.9%
Health Care Industry +1.00 4.2% +3.43% 3.4%
Mid Cap Style +2.67 4.1% +3.35% 3.4%
Residual Volatility Style +2.72 3.4% +2.79% 2.8%
Size Style -1.66 2.3% +1.85% 1.9%
Beta Style +0.67 2.1% +1.69% 1.7%
Historical Volatility Style +1.00 2.1% +1.69% 1.7%
Non-linear Size Style +3.07 1.2% +0.99% 1.0%
Amihud Illiquidity Style +2.75 1.2% +0.96% 1.0%
Leverage (Downside Vol) Style +0.57 0.5% +0.38% 0.4%
Liquidity Style +0.51 0.2% +0.18% 0.2%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-2.1-0.70.72.13.5Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -1.66 +2.10 -3.76
Non-linear Size +3.07 +1.68 +1.39
Mid Cap +2.67 +0.13 +2.54
Beta +0.67 +1.29 -0.62
Momentum +3.02 +0.72 +2.30
Short-term Reversal -0.21 -0.64 +0.43
Residual Volatility +2.72 -0.40 +3.12
Historical Volatility +1.00 +0.86 +0.14
Liquidity +0.51 +0.11 +0.40
Amihud Illiquidity +2.75 +1.16 +1.60
Turnover +0.48 +0.21 +0.28
Growth -0.98 +0.58 -1.56
Leverage (Downside Vol) +0.57 +0.14 +0.42
Skewness +0.18 +0.24 -0.06
Kurtosis -0.34 +0.21 -0.55
Max Drawdown +0.25 -0.08 +0.34

5. Industry allocation & Brinson

Industry allocation (weight, %)-10.020.050.080.0110.0Information TechnologyCommunication ServicesUtilitiesConsumer StaplesConsumer DiscretionaryIndustrialsHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 0.0% 73.6% +0.00% -19.18% +4.32% +14.12% -14.12% +14.12%
Communication Services 0.0% 2.6% +0.00% -15.54% +0.06% +0.41% -0.41% +0.41%
Utilities 0.0% 0.8% +0.00% +11.58% -0.20% -0.09% +0.09% -0.09%
Consumer Staples 0.0% 0.8% +0.00% +15.58% -0.24% -0.13% +0.13% -0.13%
Consumer Discretionary 0.0% 8.8% +0.00% +5.56% -1.66% -0.49% +0.49% -0.49%
Industrials 0.0% 11.1% +0.00% +7.16% -2.27% -0.80% +0.80% -0.80%
Health Care 100.0% 1.7% -1.85% +9.16% +22.08% -0.19% -10.82% -2.00%
Total +21.99% +12.79% -23.80% +10.98%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
TNGX TANGO THERAPEUTICS INC Health Care 65.63% +2.20% +1.45% Reduce
RLAY RELAY THERAPEUTICS INC Health Care 26.52% +0.22% +0.06% Reduce
AGMB AGOMAB THERAPEUTICS NV Health Care 7.85% -42.70% -3.35% Reduce
Contribution rank Symbol Sector Weight Return Contribution
1 TNGX Health Care 65.63% +2.20% +1.45%
2 RLAY Health Care 26.52% +0.22% +0.06%
3 AGMB Health Care 7.85% -42.70% -3.35%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-13 (32 trading days), the reported portfolio returned -1.53%, versus -13.72% for the QQQ synthetic benchmark — an excess of +12.18%.
  2. Return attribution: the largest positive style/industry contributions came from Health Care +8.12%, Residual Volatility +7.24%, Beta +3.24%; the largest drags came from Historical Volatility -12.84%, Momentum -10.08%, Mid Cap -4.52%. Specific (stock-level) return contributed +14.20%.
  3. Risk attribution: Barra model volatility is 81.79% annualised; factor risk explains 29% of variance and specific risk 71%. The largest factor risk sources are Momentum 7.2%, Health Care 4.2%, Mid Cap 4.1%.
  4. Style tilt: size -1.66, momentum +3.02, volatility +1.00, liquidity +0.51; the weighted raw beta is 1.51. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+98.3 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +21.99%, selection +12.79% and interaction -23.80%.
  6. Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did TCG Crossover Management, LLC buy in 2026-Q3?

In its 2026-Q3 13F filing, TCG Crossover Management, LLC reported 56 equity positions worth $3.54B in aggregate; its largest disclosed positions were ABVX ($362.71M), CGON ($260.18M), AMLX ($181.69M).

How large is TCG Crossover Management, LLC's portfolio?

TCG Crossover Management, LLC reported $3.54B of long equity holdings across 56 positions as of 2026-Q3. Top-10 holdings account for 53.3% of reported value.

What is TCG Crossover Management, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/tcg-crossover-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →